Structure

A dynamic, multi-disciplinary Board of prominent experts

The HPV Prevention and Control Board is composed of a group of experts as HPV Prevention and Control Board Advisers, who set the strategy and define the actions. The advisers are internationally recognised experts in the fields of HPV, HPV related cancer, public health, and vaccinology. They are able to offer high quality information and expert opinions to the target audiences of opinion leaders, policymakers, and health care professionals. They are professionally highly active in their fields of expertise, and will ensure that the HPV Prevention  Board responds rapidly and effectively as new issues emerge. Apart from academia, and national health authorities, representatives from headquarters  (WHO/HQ), the WHO regional office for Europe (WHO/EURO), IARC, GAVI, the International Papillomavirus Society (IPS), European Centre for Disease Control and Prevention (ECDC) are members of the board.

In addition to the permanent group of experts, external experts are invited on an ad hoc basis depending on the topics discussed at the meeting.

View the members of the Board
Advisers:
Dr. Marc Arbyn
Coordinator
Unit Cancer Epidemiology
Department of Public Health and Surveillance
Sciensano
Belgium
marc.arbyn@sciensano.be
Prof. Dr. Narendra Kumar Arora
Chief Scientist & Mentor
The INCLEN Trust International (INCLEN)
India
nkarora@inclentrust.org
Prof. dr. Paolo Bonanni
Professor in Public Health
Dipartimento di Scienze della Salute (DSS)
University of Florence
Italy
paolo.bonanni@unifi.it
Dr. Xavier Bosch
Senior Consultant
Catalan Institute of Oncology/IDIBELL
Spain
x.bosch@iconcologia.net
Dr. Kate Cuschieri FRCPath
Director, Scottish HPV Reference Laboratory, Royal Infirmary of Edinburgh
Scottish Human Papillomavirus Reference Laboratory | Edinburgh and Lothians Laboratory Medicine
&
Lead, HPV Research Group, Centre for Reproductive Health, University of Edinburgh
Centre for Reproductive Health | Centre for Reproductive Health
kate.cuschieri@nhslothian.scot.nhs.uk
Dr. Silvia de Sanjosé
Consultant – National Cancer Institute (NCI)
Senior Advisor to Women’s Cancer – PATH
NCI, PATH
International Papilloma Virus Society
Spain & USA
desanjosé.silvia@gmail.com
Prof. dr. Eduardo Franco
Professor Department of Oncology and Department of Epidemiology & Biostatistics
Director Division of Cancer Epidemiology
Chairman Department of Oncology
Faculty of Medicine
McGill University
Canada
eduardo.franco@mcgill.ca
Prof. dr. Suzanne Garland
Prof. Reproductive & Neonatal Infectious Diseases Department of Obstetrics and Gynaecology
Director of the Centre for Women’s Infectious Diseases (WCID) Research
Honorary Research Fellow, Infection & Immunity
University of Melbourne
The Royal Women’s Hospital, Melbourne
Murdoch Children’s Research Institute, Melbourne
Australia

Dr. Anna R. Giuliano
President, International Papillomavirus Society (IPVS)
Professor and Director, Center for Immunization and Infection Research in Cancer (CIIRC)
Moffitt Cancer Center, USA
Research Professor, American Cancer Society Clinical
anna.giuliano@moffitt.org

Prof. dr. Murat Gultekin
MD, Prof., Gyneacological Oncologist, Chair
Faculty of Medicine Hacettepe University
ESGO Prevention and Advocacy Commitee Chair and ESGO ENGAGe Chair
Turkey
mrtgultekin@yahoo.com
Dr. Sharon J.B. Hanley
Department of Academic Primary Care
Institute of Applied Health Sciences
University of Aberdeen
sharon.hanley@abdn.ac.uk
Prof. dr. Susanne Krüger Kjaer
Professor, MD, DMSc
Danish Cancer Institute
Copenhagen, Denmark
susanne@cancer.dk
Dr. Heidi Larson
Professor of Anthropology, Risk and Decision Science
Director of the Vaccine Confidence Project
London School of Hygiene and Tropical Medicine (LSHTM)
UK
Heidi.Larson@lshtm.ac.uk
Dr. Mauricio Maza
Regional Advisor for Cancer Prevention and Control
Pan American Health Organization (PAHO)
Dr. Nelly Rwamba Mugo
Senior Principal Clinical Research Scientist
Kenya Medical Research Institute
Dr. Raul Murillo
Director Javeriana Oncology Center (San Ignacio University Hospital – Bogotá, Colombia)
Associate Professor at the Faculty of Medicine – Pontifical Javeriana University (Bogotá-Colombia)
Prof. dr. Mario Poljak
Head of the Laboratory for Molecular Microbiology and Slovenian HIV/AIDS and Hepatitis Reference Center
Institute of Microbiology and Immunology
Faculty of Medicine
University of Ljubljana
Slovenia
mario.poljak@mf.uni-lj.si
Prof. Margaret Stanley
OBE., FMedSci, Hon FRCOG, Hon FFPH
Department of Pathology
University of Cambridge
UK
mas1001@cam.ac.uk
Dr. Marc Steben
Co-president
HPV global action
Montréal, Canada
Prof. dr. Pierre Van Damme
Director Centre for the Evaluation of Vaccination
Vaccine & Infectious Disease Institute
Faculty of Medicine
University of Antwerp, Belgium
pierre.vandamme@uantwerpen.be
Prof. dr. ir. Alex Vorsters
Associated Professor
Centre for the Evaluation of Vaccination
Vaccine & Infectious Disease Institute
Faculty of Medicine
University of Antwerp
Belgium
alex.vorsters@uantwerpen.be
Honorary Advisers:
Dr. Mark Kane
Consultant
USA
mark.a.kane@gmail.com
Prof. dr. Mira Kojouharova
Former Deputy Director, Head
National Centre of Infectious and Parasitic Diseases (NCIPD)
Bulgaria
mira.kojouharova@gmail.com
Dr. Nubia Muñoz
Emeritus Professor Instituto Nacional de Cancerología
Bogota, Colombia
Ad hoc Advisers:
David Hawkes
Observers:

Dr. Iacopo Baussano
International Agency for Research on Cancer (IARC)

Dr. Liudmila Mosina
WHO Euro
World Health Organization

A flexible, experienced, and well-connected Executive Secretariat

The secretariat of the HPV Prevention Board is located at the University of Antwerp, at the Vaccine & Infectious Disease Institute, within the structure of the Centre for the Evaluation of Vaccination (CEV), which has 32 years of experience of successfully running the VHPB secretariat. The CEV is a WHO Collaborating Centre for the Prevention and Control of Infectious Diseases.